IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AMALGAMATED BANK 22,306$1010.00%
Citadel Advisors 534,300$2,431,0650.00%
WOLVERINE TRADING, LLC 211,600$962,7800.00%
CAPSTONE INVESTMENT ADVISORS, LLC 28,507$129,7070.00%
NOMURA HOLDINGS INC 69,559$316,4930.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 670,600$3,051,2300.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,171,500$5,330,3250.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,245,037$5,664,9190.00%
GTS SECURITIES LLC 139,800$636,0900.00%
XPONANCE, INC. 13,459$61,2380.00%
GTS SECURITIES LLC 63,061$286,9280.00%
ProShare Advisors LLC 45,994$209,2730.00%
DekaBank Deutsche Girozentrale 100,000$4540.00%
Cutler Group LLC / CA 2,600$110.00%
Raymond James Financial Services Advisors, Inc. 87,595$398,5570.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 38,990$177,4050.00%
JPMORGAN CHASE & CO 2,746,356$12,495,9200.00%
VOYA INVESTMENT MANAGEMENT LLC 161,302$733,9250.00%
JANE STREET GROUP, LLC 549,915$2,502,1130.00%
Cresset Asset Management, LLC 45,568$207,3340.00%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.